Website outages and upgrades

Human medicines European public assessment report (EPAR): Bridion, sugammadex, Date of authorisation: 25/07/2008, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Mysimba, naltrexone,bupropion, Date of authorisation: 26/03/2015, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Temodal, temozolomide, Date of authorisation: 26/01/1999, Revision: 40, Status: Authorised

Referral: Veterinary medicinal products containing amoxicillin, amoxicillin Article 141(1)(i) procedures Procedure started

Human medicines European public assessment report (EPAR): Quadramet, samarium [153Sm] lexidronam pentasodium, Date of authorisation: 04/02/1998, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Entecavir Viatris (previously Entecavir Mylan), entecavir, Date of authorisation: 18/09/2017, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Duavive, oestrogens conjugated,bazedoxifene, Date of authorisation: 16/12/2014, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Date of authorisation: 11/03/2010, Revision: 38, Status: Authorised